Global Artificial Intelligence (AI) in Cancer Supply, Demand and Key Producers, 2026-2032
Description
The global Artificial Intelligence (AI) in Cancer market size is expected to reach $ 8031 million by 2032, rising at a market growth of 18.2% CAGR during the forecast period (2026-2032).
Artificial Intelligence (AI) in Cancer refers to the application of machine learning, deep learning, and data-driven computational models across the oncology care continuum to support cancer screening, diagnosis, treatment planning, and outcome prediction. AI systems in oncology analyze large volumes of heterogeneous data, including medical imaging, digital pathology slides, genomic and multi-omics data, and real-world clinical records, to detect patterns that exceed human cognitive limits. In clinical practice, these solutions function primarily as decision-support tools, improving diagnostic accuracy, standardizing interpretation, accelerating workflows, and enabling more personalized treatment strategies. Rather than replacing oncologists, AI augments clinical expertise by reducing variability and supporting earlier and more consistent cancer detection and management.
From a multi-angle classification and parameterization perspective, the market can be segmented by clinical application stage (screening and early detection, diagnosis and classification, treatment planning, therapy monitoring, and prognosis), by data modality (imaging-based, pathology-based, genomics-based, clinical data-driven, or multimodal fusion), and by cancer type (lung, breast, colorectal, prostate, hematologic, and rare cancers). Additional parameters that differentiate solutions include sensitivity and specificity at defined clinical thresholds, explainability of AI outputs, integration with hospital IT systems, regulatory clearance status, and scalability across institutions and geographies.
The industry value chain begins upstream with data generation and infrastructure providers, including imaging equipment manufacturers, sequencing platforms, digital pathology scanners, and cloud computing services. Midstream players consist of AI oncology solution developers that curate datasets, train models, and package algorithms into regulated software or integrated platforms. Downstream customers include hospitals, cancer centers, diagnostic laboratories, pharmaceutical companies, and population-level screening programs, often adopting AI tools through enterprise licenses or software-as-a-service models.
From a profitability standpoint, AI in Cancer solutions typically exhibit gross margins in the 65–85% range, reflecting their software-centric economics once development and regulatory costs are absorbed. Cloud-based platforms and AI-as-a-service models tend to achieve the highest margins, while device-embedded solutions trade some margin for faster adoption through OEM partnerships. Market growth is driven by rising cancer incidence, shortages of oncology specialists, increasing data complexity, and the shift toward precision medicine. Key trends include multimodal data integration, expansion from detection to outcome prediction, deeper OEM and hospital integration, and growing use of AI to support value-based oncology care.
This report studies the global Artificial Intelligence (AI) in Cancer demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Artificial Intelligence (AI) in Cancer, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Intelligence (AI) in Cancer that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Artificial Intelligence (AI) in Cancer total market, 2021-2032, (USD Million)
Global Artificial Intelligence (AI) in Cancer total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Artificial Intelligence (AI) in Cancer total market, key domestic companies, and share, (USD Million)
Global Artificial Intelligence (AI) in Cancer revenue by player, revenue and market share 2021-2026, (USD Million)
Global Artificial Intelligence (AI) in Cancer total market by Type, CAGR, 2021-2032, (USD Million)
Global Artificial Intelligence (AI) in Cancer total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Artificial Intelligence (AI) in Cancer market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PathAI, PaigeAI, Lunit, INFERVISION TECHNOLOGY, Aidoc, VUNO, Inc., ANNALISE-AI PTY LTD, BioMind, YITU Technology, Shukun Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Artificial Intelligence (AI) in Cancer market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Artificial Intelligence (AI) in Cancer Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Artificial Intelligence (AI) in Cancer Market, Segmentation by Type:
Medical Imaging–based AI
Digital Pathology–based AI
Genomics & Multi-omics AI
Others
Global Artificial Intelligence (AI) in Cancer Market, Segmentation by AI Function Depth:
Detection & Flagging
Segmentation & Quantification
Classification & Grading
Prediction & Outcome Modeling
Others
Global Artificial Intelligence (AI) in Cancer Market, Segmentation by Product Form & Commercial Model:
Device-embedded AI Systems
Standalone Software / SaaS Platforms
AI-as-a-Service for Oncology
Others
Global Artificial Intelligence (AI) in Cancer Market, Segmentation by Application:
Lung Cancer
Breast Cancer
Colorectal & GI Cancers
Prostate & Urological Cancers
Hematologic & Rare Cancers
Others
Companies Profiled:
PathAI
PaigeAI
Lunit
INFERVISION TECHNOLOGY
Aidoc
VUNO, Inc.
ANNALISE-AI PTY LTD
BioMind
YITU Technology
Shukun Technology
Beijing Huiyi Huiying Medical Technology
Shenzhen Keya Medical Technology
Densitas
Volpara
Niramai
MVision AI
MammoScreen
Perimeter Medical Imaging AI
ICAD
LungLifeAI
Nanox.AI
Varian Medical Systems
Canon Medical
GE Healthcare
Philips
Key Questions Answered
1. How big is the global Artificial Intelligence (AI) in Cancer market?
2. What is the demand of the global Artificial Intelligence (AI) in Cancer market?
3. What is the year over year growth of the global Artificial Intelligence (AI) in Cancer market?
4. What is the total value of the global Artificial Intelligence (AI) in Cancer market?
5. Who are the Major Players in the global Artificial Intelligence (AI) in Cancer market?
6. What are the growth factors driving the market demand?
Artificial Intelligence (AI) in Cancer refers to the application of machine learning, deep learning, and data-driven computational models across the oncology care continuum to support cancer screening, diagnosis, treatment planning, and outcome prediction. AI systems in oncology analyze large volumes of heterogeneous data, including medical imaging, digital pathology slides, genomic and multi-omics data, and real-world clinical records, to detect patterns that exceed human cognitive limits. In clinical practice, these solutions function primarily as decision-support tools, improving diagnostic accuracy, standardizing interpretation, accelerating workflows, and enabling more personalized treatment strategies. Rather than replacing oncologists, AI augments clinical expertise by reducing variability and supporting earlier and more consistent cancer detection and management.
From a multi-angle classification and parameterization perspective, the market can be segmented by clinical application stage (screening and early detection, diagnosis and classification, treatment planning, therapy monitoring, and prognosis), by data modality (imaging-based, pathology-based, genomics-based, clinical data-driven, or multimodal fusion), and by cancer type (lung, breast, colorectal, prostate, hematologic, and rare cancers). Additional parameters that differentiate solutions include sensitivity and specificity at defined clinical thresholds, explainability of AI outputs, integration with hospital IT systems, regulatory clearance status, and scalability across institutions and geographies.
The industry value chain begins upstream with data generation and infrastructure providers, including imaging equipment manufacturers, sequencing platforms, digital pathology scanners, and cloud computing services. Midstream players consist of AI oncology solution developers that curate datasets, train models, and package algorithms into regulated software or integrated platforms. Downstream customers include hospitals, cancer centers, diagnostic laboratories, pharmaceutical companies, and population-level screening programs, often adopting AI tools through enterprise licenses or software-as-a-service models.
From a profitability standpoint, AI in Cancer solutions typically exhibit gross margins in the 65–85% range, reflecting their software-centric economics once development and regulatory costs are absorbed. Cloud-based platforms and AI-as-a-service models tend to achieve the highest margins, while device-embedded solutions trade some margin for faster adoption through OEM partnerships. Market growth is driven by rising cancer incidence, shortages of oncology specialists, increasing data complexity, and the shift toward precision medicine. Key trends include multimodal data integration, expansion from detection to outcome prediction, deeper OEM and hospital integration, and growing use of AI to support value-based oncology care.
This report studies the global Artificial Intelligence (AI) in Cancer demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Artificial Intelligence (AI) in Cancer, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Intelligence (AI) in Cancer that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Artificial Intelligence (AI) in Cancer total market, 2021-2032, (USD Million)
Global Artificial Intelligence (AI) in Cancer total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Artificial Intelligence (AI) in Cancer total market, key domestic companies, and share, (USD Million)
Global Artificial Intelligence (AI) in Cancer revenue by player, revenue and market share 2021-2026, (USD Million)
Global Artificial Intelligence (AI) in Cancer total market by Type, CAGR, 2021-2032, (USD Million)
Global Artificial Intelligence (AI) in Cancer total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Artificial Intelligence (AI) in Cancer market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PathAI, PaigeAI, Lunit, INFERVISION TECHNOLOGY, Aidoc, VUNO, Inc., ANNALISE-AI PTY LTD, BioMind, YITU Technology, Shukun Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Artificial Intelligence (AI) in Cancer market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Artificial Intelligence (AI) in Cancer Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Artificial Intelligence (AI) in Cancer Market, Segmentation by Type:
Medical Imaging–based AI
Digital Pathology–based AI
Genomics & Multi-omics AI
Others
Global Artificial Intelligence (AI) in Cancer Market, Segmentation by AI Function Depth:
Detection & Flagging
Segmentation & Quantification
Classification & Grading
Prediction & Outcome Modeling
Others
Global Artificial Intelligence (AI) in Cancer Market, Segmentation by Product Form & Commercial Model:
Device-embedded AI Systems
Standalone Software / SaaS Platforms
AI-as-a-Service for Oncology
Others
Global Artificial Intelligence (AI) in Cancer Market, Segmentation by Application:
Lung Cancer
Breast Cancer
Colorectal & GI Cancers
Prostate & Urological Cancers
Hematologic & Rare Cancers
Others
Companies Profiled:
PathAI
PaigeAI
Lunit
INFERVISION TECHNOLOGY
Aidoc
VUNO, Inc.
ANNALISE-AI PTY LTD
BioMind
YITU Technology
Shukun Technology
Beijing Huiyi Huiying Medical Technology
Shenzhen Keya Medical Technology
Densitas
Volpara
Niramai
MVision AI
MammoScreen
Perimeter Medical Imaging AI
ICAD
LungLifeAI
Nanox.AI
Varian Medical Systems
Canon Medical
GE Healthcare
Philips
Key Questions Answered
1. How big is the global Artificial Intelligence (AI) in Cancer market?
2. What is the demand of the global Artificial Intelligence (AI) in Cancer market?
3. What is the year over year growth of the global Artificial Intelligence (AI) in Cancer market?
4. What is the total value of the global Artificial Intelligence (AI) in Cancer market?
5. Who are the Major Players in the global Artificial Intelligence (AI) in Cancer market?
6. What are the growth factors driving the market demand?
Table of Contents
164 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Artificial Intelligence (AI) in Cancer Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by AI Function Depth
- 7 Market Analysis by Product Form & Commercial Model
- 8 Market Analysis by Application
- 9 Company Profiles
- 10 Industry Chain Analysis
- 11 Research Findings and Conclusion
- 12 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
